Operator fluency on fresh ground

Surmodics, Inc. (SRDX) — this company's answers

The model's full reasoning — Q3 2018 call → NOWe need to answer YES or NO based on the transcript. The question asks: "On this call, when analysts probe a RECENTLY EMERGED positive element of the business — something whose meaningful contribution began only within roughly the last few quarters — does management respond with UNHESITATING, GRANULAR OPERATIONAL COMMAND: answering follow-up questions about that new element with specific, present-tense working detail ... while conveying that the element's contribution to the reported results is still early?" We need to identify if there is such an element probed by analysts. The analysts ask about several things: the Abbott SurVeil agreement (revenue from that), the BTK and AV fistula programs, the Embolitech thrombectomy technology, the diagnostics business, etc. The question specifically asks about a "recently emerged positive element" whose meaningful contribution began only within roughly the last few quarters. The Abbott SurVeil agreement is recent (announced late February 2018, so within the last few quarters). Analysts probe that: Brooks asks about the BTK and AV fistula programs, but that's not necessarily a "positive element" that has contributed to results yet. Jim asks about the Abbott revenue and whether similar revenue should be expected. Mike asks about the deferred revenue and what happens after it runs out. Also Mike asks about Embolitech. But the question is about management's response to analysts probing a recently emerged positive element. The element could be the Abbott SurVeil agreement, which is generating revenue now (license fee revenue). Analysts ask about it: Jim asks about the $1.7 million from Abbott and whether similar revenue should be expected. Tim answers with guidance and deferred revenue, but that's more financial housekeeping. Mike asks about the deferred revenue and what happens after it runs out. Tim explains the revenue recognition over the enrollment period and beyond. That is somewhat granular but it's about accounting and timing, not operational detail like how it's being produced, delivered, staffed, etc. The question asks for "specific, present-tense working detail (how it is actually being produced, delivered, staffed, scheduled, priced, or scaled; which kinds of counterparties are taking it and how they behave; what the company is doing this month and next to serve it)".

← Back to the full SRDX analysis